Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
Paris - Delayed Quote EUR

Adocia SA (ADOC.PA)

Compare
3.3900
-0.3600
(-9.60%)
At close: April 4 at 5:35:24 PM GMT+2
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
523
2,150
11,447
1,444
841
Cost of Revenue
--
765
1,839
1,264
1,457
Gross Profit
--
1,385
9,608
180
-616
Operating Expense
14,977
15,629
11,305
19,545
20,533
Operating Income
-15,219
-14,244
-1,697
-19,365
-21,149
Net Non Operating Interest Income Expense
-626
-1,261
-2,443
-2,259
-2,056
Pretax Income
-20,716
-21,160
-6,425
-22,754
-23,295
Tax Provision
--
2
476
--
29
Net Income Common Stockholders
-20,715
-21,162
-6,901
-22,754
-23,324
Diluted NI Available to Com Stockholders
-20,715
-21,162
-6,901
-22,754
-23,324
Basic EPS
-1.50
-1.90
-0.90
-3.20
-3.30
Diluted EPS
-1.50
-1.90
-0.90
-3.20
-3.30
Basic Average Shares
13,677.4840
14,087.3830
8,031.5270
7,057.6000
6,973.6390
Diluted Average Shares
13,677.4840
14,087.3830
8,031.5270
7,057.6000
6,973.6390
Total Operating Income as Reported
-15,220
-14,244
-1,698
-19,366
-21,148
Total Expenses
15,742
16,394
13,144
20,809
21,990
Net Income from Continuing & Discontinued Operation
-20,715
-21,162
-6,901
-22,754
-23,324
Normalized Income
-15,807
-16,972.5000
-5,093.5000
-21,449
-23,478.0800
Interest Income
22
83
28
1
10
Interest Expense
613
1,308
2,292
2,249
2,066
Net Interest Income
-626
-1,261
-2,443
-2,259
-2,056
EBIT
-20,103
-19,852
-4,133
-20,505
-21,229
EBITDA
-19,578
-19,353
-3,576
-19,490
-20,030
Reconciled Cost of Revenue
--
765
1,839
1,264
1,457
Reconciled Depreciation
515
499
557
1,015
1,198
Net Income from Continuing Operation Net Minority Interest
-20,715
-21,162
-6,901
-22,754
-23,324
Total Unusual Items Excluding Goodwill
-4,908
-5,586
-2,410
-1,305
214
Total Unusual Items
-4,908
-5,586
-2,410
-1,305
214
Normalized EBITDA
-14,670
-13,767
-1,166
-18,185
-20,244
Tax Rate for Calcs
--
0.0003
0.0003
--
0.0003
Tax Effect of Unusual Items
--
-1,396.5000
-602.5000
--
59.9200
12/31/2020 - 2/20/2012

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ALTHX.PA Theranexus Société Anonyme
0.4300
-0.46%
 
1U5.SG Wave Life Sciences Ltd.
5.45
-9.17%
 
OSE.PA OSE Immunotherapeutics SA
5.16
-6.35%
 
POXEL.PA Poxel S.A.
0.2140
-9.89%
 
ADXN Addex Therapeutics Ltd
7.43
+1.78%
 
ABNX.PA ABIONYX Pharma SA
1.2100
-3.04%
 
ALSEN.PA Sensorion SA
0.3880
-5.37%
 
ALVAL.PA Valbiotis SA
1.0700
+1.90%
 
ALNEV.PA Neovacs S.A.
0.0409
-8.91%
 
BIOV.SW BioVersys AG
35.10
-2.50%